Skip to main content
Caplight Logo









AdjuCor

AdjuCor

Private
MunichHealthcare & Life Scienceshttps://adjucor.com/

Last Round

Grant

Jun 9, 2022

Total Funding Raised

$38M

Company Overview

AdjuCor is a medical device company that has developed a novel, patient-specific, extravascular, non-blood-contacting cardiac support technology for the treatment of advanced heart failure.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Precision Medicine, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

heart assist deviceextravascular cardiac supportmechanical circulatory supportventricular assist deviceVADbiventricular supportadvanced heart failurenon-blood-contactingpulsatile supportimplantable medical devicemedtechcardiac surgeryheart transplant alternativepatient-specific deviceclinical stage company

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AdjuCor Comparables

Compare AdjuCor with similar companies based on industry and business-model similarity.

AdjuCor comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CorWave
83%
Evaheart, Inc.
79%
BiVACOR
78%

AdjuCor Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 9, 2022
Series BJun 9, 2021

Key People

Founding team and executive leadership

Stephen Wildhirt

Co-Founder and CEO

Founding Team

Johannes Clauss

COO CTO

Executive Team

AdjuCor Investors

Notable investors and investment history

AdjuCor investors
InvestorRounds
European Innovation Council FundGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 9, 2022

    Secured $2.68M from the European Innovation Council Fund.

AdjuCor Filings

Explore SEC and related filing metadata, where available.

AdjuCor filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AdjuCor's valuation, stock price, and market status.

Is AdjuCor a public or private company?

AdjuCor is a private company.

What is the current stock price of AdjuCor?

AdjuCor is a private company with no public stock price. No recent secondary market data is available.

How much is AdjuCor worth (valuation)?

Valuation information for AdjuCor is not publicly available.

Can I buy AdjuCor stock?

AdjuCor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AdjuCor's last funding round?

AdjuCor's most recent funding round was Grant on June 9, 2022.

Who are the main investors in AdjuCor?

Key investors in AdjuCor include European Innovation Council Fund.

Will AdjuCor IPO soon?

No public IPO plans have been announced for AdjuCor.

How can I track AdjuCor secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AdjuCor's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMunich
Employee Range23
Year Founded2012
Last FundingJun 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?